Skip to content

INTELLIPHARMACEUTICS INTERNATIONAL INC.

CIK 0001474835

← back to feed
Revenue (TTM)
$825.61K
Q3 Aug 2023
Net Income (TTM)
−$2.59M
+43.8% YoY Q3 Aug 2023
EPS Diluted (TTM)
$0.02
Q3 Aug 2023
Gross Margin
-95.2%
Q3 Aug 2023
Operating Margin
-301.1%
Q3 Aug 2023
Net Margin
-313.8%
Q3 Aug 2023
Free Cash Flow (TTM)
$19.36K
Q3 Aug 2023
Cash
$69.55K
Q3 Aug 2023
Total Debt
—
Q3 Aug 2023
Shares Outstanding
33.09M sh
Q3 Aug 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings